>
Switch to:

Turning Point Therapeutics Change In Payables And Accrued Expense

: $10.52 Mil (TTM As of Mar. 2021)
View and export this data going back to 2019. Start your Free Trial

Turning Point Therapeutics's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2021 was $4.23 Mil. It means Turning Point Therapeutics's Accounts Payable & Accrued Expense increased by $4.23 Mil from Dec. 2020 to Mar. 2021 .

Turning Point Therapeutics's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2020 was $7.20 Mil. It means Turning Point Therapeutics's Accounts Payable & Accrued Expense increased by $7.20 Mil from Dec. 2019 to Dec. 2020 .


Turning Point Therapeutics Change In Payables And Accrued Expense Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turning Point Therapeutics Annual Data
Dec17 Dec18 Dec19 Dec20
Change In Payables And Accrued Expense 3.36 -1.06 1.43 7.20

Turning Point Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Change In Payables And Accrued Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 -1.09 6.28 1.10 4.23

Turning Point Therapeutics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2021 was -1.092 (Jun. 2020 ) + 6.283 (Sep. 2020 ) + 1.095 (Dec. 2020 ) + 4.232 (Mar. 2021 ) = $10.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turning Point Therapeutics Change In Payables And Accrued Expense Related Terms


Turning Point Therapeutics Change In Payables And Accrued Expense Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)